COL Immunotherapy Before Radiochimio + Ipilimumab
NCT04256213
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Cervix Cancer
Interventions
DRUG:
Nivolumab and Ipilimumab
Sponsor
ARCAGY/ GINECO GROUP
Collaborators
[object Object]